Newsfiscal.ai
HC Wainwright Adjusts Price Target for Aardvark Therapeutics
· Published
Article summary
HC Wainwright has lowered its price target for Aardvark Therapeutics from $4.00 to $2.00 while maintaining a Neutral rating.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…